60 Results for "

Cbl

" in MedChemExpress (MCE) Product Catalog:
Products (60)

60 Results for "Cbl" in MCE Product Catalog:

12
12 Publications Verification
Cat. No.: HY-18935
CAS No.: 1197996-80-7
Synonyms: Curaxin 137; Cbl-C137
Research Areas:  

Cancer

CBL0137, a curaxin compound, is a histone chaperone facilitates chromatin transcription (FACT) inhibitor. CBL0137 downregulates NF-κB and activates p53. CBL0137 restores both histone H3 acetylation and trimethylation. CBL0137 is an anticancer agent. CBL0137 induces cancer cell apoptosis .
12
12 Publications Verification
Cat. No.: HY-18935A
CAS No.: 1197397-89-9
Synonyms: Curaxin-137 hydrochloride; Cbl-C137 hydrochloride
Target:  

MDM-2/p53 NF-κB

Research Areas:  

Cancer

CBL0137 hydrochloride is an inhibitor of the histone chaperone, FACT. CBL0137 hydrochloride can also activate p53 and inhibits NF-κB with EC50s of 0.37 and 0.47 μM, respectively.
3
3 Cited Publications
Cat. No.: HY-B2209
CAS No.: 13422-51-0
Synonyms: Vitamin B12a
Hydroxocobalamin (Vitamin B12a) is a cyanide antidote. Hydroxocobalamin can decrease the cell and plasma cyanide concentrations and increase survival rate in acute cyanide poisoning. Hydroxocobalamin can improve newborn Cbl-C defect-induced metabolic profile and neurocognitive outcome. Hydroxocobalamin can normalize Vitamin B12 deficiency. Hydroxocobalamin can induce acute kidney injury. Hydroxocobalamin can be used for the researches of metabolic and neurological disease .
1
1 Cited Publications
Cat. No.: HY-136339
CAS No.: 2368841-84-1
Purity:  99.66%
Cbl-b-IN-1 (Example 519) is an inhibitor of Cbl-b, with an IC50 of less than 100 nM. Cbl-b-IN-1 can promote the secretion of cytokines such as IL-2, IFN-γ, and TNF-α, facilitate T cell activation, and enhance the TCR signaling pathway. Cbl-b-IN-1 can be used in research on immunomodulation .
1
1 Cited Publications
Cat. No.: HY-W176629
CAS No.: 550-10-7
Hydrocotarnine is a Cbl inhibitor, and results in inflammasome-mediated IL-18 secretion in colitis. Hydrocotarnine increases expression of GLUT1 and cellular glucose uptake in glycolytic metabolism. Hydrocotarnine acts as an agent that provides analgesic effect in cancer research .
Cat. No.: HY-141432
CAS No.: 2573775-59-2
Purity:  99.87%
Synonyms: Cbl-b-IN-3
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Cancer

NX-1607 (Compound 23) is an inhibitor of Cbl-b, an E3 enzyme in the ubiquitin-proteasome pathway, with an IC50 value of less than 1 nM. NX-1607 can be used in cancer research .
Cat. No.: HY-P10412
CAS No.: 2412926-30-6
Synonyms: ANXA1-derived 11 amino acid-long peptide
Research Areas:  

Cancer

A11 (ANXA1-derived 11 amino acid-long peptide) is a ANXA1-EphA2 interaction-blocking peptide. A11 reduces ANXA1 bound to EphA2 and increases Cbl (the E3 ubiquitin ligase of EphA2) bound to EphA2. A11 inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells. A11 inhibits angiogenesis. A11 can be used in studies related to nasopharyngeal carcinoma .
Cat. No.: HY-156766
CAS No.: 2815225-12-6
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Cancer

Cbl-b-IN-10 is a Cbl-b and c-Cbl inhibitor with IC50 values of 6.0 nM and 3.5 nM, respectively. Cbl-b-IN-10 can be used in the study of cancer .
Cat. No.: HY-155120
CAS No.: 2368835-59-8
Purity:  99.61%
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Inflammation/Immunology Cancer

Cbl-b-IN-5 (compound 6) is a Cbl-b inhibitor (IC50=3-10 µM). Cbl-b-IN-5 has the potential to be used in the study of cancer and related diseases amenable to immune system modulation .
Cat. No.: HY-155477
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Cancer

Cbl-b-IN-15 (compound 25) is an inhibitor of the RING finger E3 ligase Cbl (IC50: 15 nM). Cbl-b refers to Casitas B-lineage lymphoma proto-oncogene-b, which inhibits T-cell, natural killer (NK) cell, and B-cell activation. Cbl-b-IN-15 activates T cell function with EC50=0.41 μM .
Cat. No.: HY-156769
CAS No.: 2368841-85-2
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Inflammation/Immunology

Cbl-b-IN-13 (Example 520) is a Cbl-b inhibitor with an IC50 of <100 nM. Cbl-b-IN-13 has the ability to activate T-cells .
Cat. No.: HY-161977
CAS No.: 3035443-17-2
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Inflammation/Immunology

Cbl-b-IN-26 (Example A1) is a Cbl-b inhibitor with a Kd of 34.6 nM . Cbl-b-IN-26 can be used in the study of chronic viral infections and cancer .
Cat. No.: HY-156765
CAS No.: 2815223-41-5
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Cancer

Cbl-b-IN-9 (Compound 300) is a casitas B-lineage lymphoma-b (Cbl-b) and c-Cbl inhibitor with IC50s of 5.6 nM and 4.7 nM, respectively .
Cat. No.: HY-159615
CAS No.: 2851878-87-8
Cbl-b-IN-21 is a PROTAC target protein ligand (Ligands for Target Protein for PROTACs). Cbl-b-IN-21 can be used for synthesis PROTAC Cbl-b-IN-1 (HY-159608) .
Cat. No.: HY-156768
CAS No.: 2851871-29-7
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Cancer

Cbl-b-IN-12 (Example 10) is a casitas B-lineage lymphoma-b (CBL-B) inhibitor with an IC50 of <100 nM .
Cat. No.: HY-E70079
CAS No.: 9055-05-4
Synonyms: Cbl
Research Areas:  

Infection

Cystathionine β-lyase, Recombinant Microorganisms (CBL) is an enzyme that catalyzes the breakdown of cystathionine to homocysteine, the penultimate step in methionine biosynthesis. Cystathionine β-lyase is important for bacterial virulence .
Cat. No.: HY-156764
CAS No.: 2815223-33-5
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Cancer

Cbl-b-IN-8 (Compound 293) is a casitas B-lineage lymphoma-b (Cbl-b) and c-Cbl inhibitor with IC50s of 5.5 nM and 7.8 nM, respectively .
Cat. No.: HY-141431
CAS No.: 2503325-21-9
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Inflammation/Immunology Cancer

Cbl-b-IN-2 (Example 8) is an orally bioavailable compound, can inhibit the E3 enzyme Casitas B-lineage lymphoma proto-oncogene-b (Cbl-b) in the ubiquitin proteasome pathway. Cbl-b-IN-2 can be used to modulate the immune system and diseases amenable to immune system modulation. Cbl-b-IN-2 (Example 8) also may be administered to an individual with cancer, either alone or as part of a combination, with one or more of an immune checkpoint inhibitor, an anti-neoplastic agent, and radiation agent .
Cat. No.: HY-P10412A
Synonyms: ANXA1-derived 11 amino acid-long peptide acetate
Research Areas:  

Cancer

A11 (ANXA1-derived 11 amino acid-long peptide) acetate is a ANXA1-EphA2 interaction-blocking peptide. A11 acetate reduces ANXA1 bound to EphA2 and increases Cbl (the E3 ubiquitin ligase of EphA2) bound to EphA2. A11 acetate inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells. A11 acetate inhibits angiogenesis. A11 acetate can be used in studies related to nasopharyngeal carcinoma .
Cat. No.: HY-158173
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Inflammation/Immunology Cancer

Cbl-b-IN-19 (Compound 49) is an inhibitor for casitas B-lineage lymphoma b(Cbl-b), that inhibits Cbl-b phosphorylation with an IC50 < 100 nM .